Iovance Stock Hits 52-Week High: Is the Rally Sustainable?
Iovance Biotherapeutics (NASDAQ: IOVA) shares surged to a new 52-week high on August 6 after the company reported robust second-quarter earnings, signaling strong commercial momentum for its flagship cancer therapy,…
